Moeti said Meningococcal meningitis A epidemics had been nearly eliminated from Africa. “We now need to urgently make progress in our fight against other strains of meningococcal meningitis, learning from the spectacular success of MenAfriVac. The price of MenAfriVac, at less than $0.50 per dose, ensured that this vaccine is a sustainable public health solution. “In the past year, both Niger and Nigeria have suffered outbreaks of meningitis C, and meningitis W135 is responsible for the current outbreak in Togo. Meningitis X also remains a threat.
Source: Medical World News